<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04000633</url>
  </required_header>
  <id_info>
    <org_study_id>lidoca√Øne cough prevention</org_study_id>
    <nct_id>NCT04000633</nct_id>
  </id_info>
  <brief_title>Nebulized Lidocaine to Prevent Cough at Emergence From Anesthesia</brief_title>
  <official_title>Nebulized Lidocaine Versus Placebo to Prevent Cough at Emergence From Anesthesia: a Double Blind Prospective Randomised Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mongi Slim Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mongi Slim Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      our study aimed to evaluate the effect of nebulized lidocaine to decrease the incidence of
      cough and sore throat after extubation after surgeries requiring endotracheal intubation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      our study aimed to evaluate the effect of nebulized lidocaine to decrease the incidence of
      cough and sore throat after extubation after surgeries requiring endotracheal intubation.

      This randomized controlled study will compare the effect of Lidocaine and placebo
      nebulization in the immediate pre operative period in order to evaluate the effectiveness in
      reducing post extubation cough and sore throat.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 groups comparaison between nebulized lidocaine versus placebo for prevention of cough at emergence from general anesthesia and post extubation sore throat</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>The investigator will provide to the anesthesiologist 1 seringue containing either lidocaine or normal saline to be nebulized before induction of general anesthesia</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of cough at emergence from general anesthesia</measure>
    <time_frame>30 minutes after the end of surgery</time_frame>
    <description>evaluation of incidence of cough at emergence from general anesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of sore throat</measure>
    <time_frame>24 hours after tracheal extubation</time_frame>
    <description>evaluation of incidence of sore throat</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cough, General Anesthesia, Extubation, Lidocaine, Sore Throat</condition>
  <arm_group>
    <arm_group_label>lidocaine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the patients of this group will recieve nebulization of 5 ml of 2% lidocaine prior to induction of general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>the patients of this group will recieve nebulization of 5 ml of normal saline prior to induction of general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 2%</intervention_name>
    <description>the patients of this group will recieve nebulization of 5 ml of 2% lidocaine prior to induction of general anesthesia</description>
    <arm_group_label>lidocaine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Normal saline</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt;18 years

          -  ASA status I or II

        Exclusion Criteria:

          -  Unexpected difficult laryngoscopy

          -  Surgery&gt;3 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mhamed Sami Mebazaa, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mongi Slim Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mhamed Sami Mebazaa, professor</last_name>
    <phone>0021622252589</phone>
    <email>msmebazaa@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hajer Arfaoui</last_name>
    <phone>0021699336661</phone>
    <email>hejer_arfaoui@hotmail.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mongi Slim Hospital</name>
      <address>
        <city>La Marsa</city>
        <state>Tunis</state>
        <zip>2046</zip>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mhamed Sami Mebazaa, professor</last_name>
      <phone>0021622252589</phone>
      <email>msmebazaa@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Asma Ben Souissi, Ass Prof</last_name>
      <phone>0021698336883</phone>
      <email>bsouissiasma@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 26, 2019</study_first_submitted>
  <study_first_submitted_qc>June 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2019</study_first_posted>
  <last_update_submitted>June 26, 2019</last_update_submitted>
  <last_update_submitted_qc>June 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mongi Slim Hospital</investigator_affiliation>
    <investigator_full_name>Mhamed Sami Mebazaa</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
    <mesh_term>Cough</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

